Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.35
-0.03 (-0.56%)
Jun 22, 2026, 4:00 PM EDT - Market closed
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $500.27 million as of June 22, 2026. Its market cap has decreased by -6.56% in one year.
Market Cap
500.27M
Enterprise Value
619.57M
1-Year Change
-6.56%
Ranking
Category
Stock Price
$5.35
Market Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $500.27M, a decrease of -61.30%. That is a compound annual growth rate of -16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 500.27M | -33.67% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 126.51% |
| May 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 525.34M |
| Altimmune | 525.08M |
| Rezolute | 524.42M |
| Eikon Therapeutics | 520.27M |
| 4D Molecular Therapeutics | 504.99M |
| Neurogene | 498.23M |
| Achieve Life Sciences | 497.90M |
| Arvinas | 494.88M |